• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An overview of respiratory syncytial virus.

作者信息

Meng Jia, Stobart Christopher C, Hotard Anne L, Moore Martin L

机构信息

Department of Pediatrics, Emory University, Atlanta, Georgia, United States of America; Children's Healthcare of Atlanta, Atlanta, Georgia, United States of America.

出版信息

PLoS Pathog. 2014 Apr 24;10(4):e1004016. doi: 10.1371/journal.ppat.1004016. eCollection 2014 Apr.

DOI:10.1371/journal.ppat.1004016
PMID:24763387
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3999198/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16f7/3999198/4d17be4b71de/ppat.1004016.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16f7/3999198/4d17be4b71de/ppat.1004016.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16f7/3999198/4d17be4b71de/ppat.1004016.g001.jpg

相似文献

1
An overview of respiratory syncytial virus.呼吸道合胞病毒概述
PLoS Pathog. 2014 Apr 24;10(4):e1004016. doi: 10.1371/journal.ppat.1004016. eCollection 2014 Apr.
2
Protection of neonates and infants by maternal immunization.通过母体免疫保护新生儿和婴儿。
Expert Rev Vaccines. 2016 Nov;15(11):1347-1349. doi: 10.1080/14760584.2016.1195266. Epub 2016 Jun 8.
3
New vaccines against mucosal pathogens: rotavirus and respiratory syncytial virus.
Adv Pediatr Infect Dis. 1997;13:333-48.
4
[Pathogenesis of respiratory syncytial virus infection].
Zhonghua Er Ke Za Zhi. 2006 Sep;44(9):673-5.
5
Preparing for the future implementation of respiratory syncytial virus vaccines.为呼吸道合胞病毒疫苗的未来实施做准备。
Lancet Respir Med. 2020 Mar;8(3):233-235. doi: 10.1016/S2213-2600(19)30478-3. Epub 2020 Jan 21.
6
Respiratory syncytial virus and innate immunity: a complex interplay of exploitation and subversion.呼吸道合胞病毒与固有免疫：利用与颠覆的复杂相互作用
Expert Rev Vaccines. 2006 Jun;5(3):371-80. doi: 10.1586/14760584.5.3.371.
7
A new direction in understanding the pathogenesis of respiratory syncytial virus bronchiolitis: how real infants suffer.理解呼吸道合胞病毒细支气管炎发病机制的新方向：真实患儿的患病情况
J Infect Dis. 2007 Apr 15;195(8):1084-6. doi: 10.1086/512622. Epub 2007 Mar 9.
8
Challenges and opportunities for respiratory syncytial virus vaccines.呼吸道合胞病毒疫苗面临的挑战与机遇。
Curr Top Microbiol Immunol. 2013;372:391-404. doi: 10.1007/978-3-642-38919-1_20.
9
Subunit and virus-like particle vaccine approaches for respiratory syncytial virus.呼吸道合胞病毒的亚单位和病毒样颗粒疫苗方法。
Curr Top Microbiol Immunol. 2013;372:285-306. doi: 10.1007/978-3-642-38919-1_14.
10
Immune monitoring of children with respiratory syncytial virus infection.呼吸道合胞病毒感染儿童的免疫监测
Expert Rev Clin Immunol. 2013 May;9(5):393-5. doi: 10.1586/eci.13.20.

引用本文的文献

1
Nasal delivery of killed spores protects against influenza, RSV and SARS-CoV-2.经鼻腔递送灭活孢子可预防流感、呼吸道合胞病毒和新型冠状病毒。
Front Immunol. 2025 Apr 2;16:1501907. doi: 10.3389/fimmu.2025.1501907. eCollection 2025.
2
Evaluation of dual pathogen recognition receptor agonists as adjuvants for respiratory syncytial virus - virus-like particles for pulmonary delivery.评估双病原体识别受体激动剂作为呼吸道合胞病毒-病毒样颗粒肺部给药佐剂的效果。
Front Immunol. 2025 Mar 17;16:1561297. doi: 10.3389/fimmu.2025.1561297. eCollection 2025.
3
Cedar virus biology and its applications as a surrogate for highly pathogenic henipaviruses.

本文引用的文献

1
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody.四种副黏病毒与人源单克隆抗体的交叉中和作用。
Nature. 2013 Sep 19;501(7467):439-43. doi: 10.1038/nature12442. Epub 2013 Aug 18.
2
A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice.呼吸道合胞病毒（RSV）抗 G 蛋白 F(ab')2 单克隆抗体抑制 RSV rA2-line19F 感染的 BALB/c 小鼠的粘液产生和呼吸努力。
J Virol. 2013 Oct;87(20):10955-67. doi: 10.1128/JVI.01164-13. Epub 2013 Jul 24.
3
Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody.
雪松病毒生物学及其作为高致病性亨尼帕病毒替代物的应用。
Cell Insight. 2024 Jul 2;3(4):100181. doi: 10.1016/j.cellin.2024.100181. eCollection 2024 Aug.
4
[Not Available].[无可用内容]
J Prev Med Hyg. 2024 Jun 30;65(2 Suppl 1):E1-E159. doi: 10.15167/2421-4248/jpmh2024.65.2s1. eCollection 2024 Sep.
5
All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design?所有目光都聚焦在预融合稳定的F结构上，但我们是否忽略了呼吸道合胞病毒疫苗设计中替代靶点的潜力？
Vaccines (Basel). 2024 Jan 18;12(1):97. doi: 10.3390/vaccines12010097.
6
Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease.帕利珠单抗预防严重呼吸道合胞病毒（RSV）疾病的安全性、有效性和耐受性综述。
Drug Healthc Patient Saf. 2023 Sep 11;15:103-112. doi: 10.2147/DHPS.S348727. eCollection 2023.
7
Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants.用于预防、诊断和治疗病毒性呼吸道感染的纳米结构：从流感病毒到 SARS-CoV-2 变体。
J Nanobiotechnology. 2023 Jun 21;21(1):199. doi: 10.1186/s12951-023-01938-8.
8
A computational approach to design a polyvalent vaccine against human respiratory syncytial virus.一种针对人类呼吸道合胞病毒的多价疫苗设计的计算方法。
Sci Rep. 2023 Jun 15;13(1):9702. doi: 10.1038/s41598-023-35309-y.
9
Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein.针对呼吸道合胞病毒（RSV）G 蛋白的免疫预防。
Viruses. 2023 Apr 27;15(5):1067. doi: 10.3390/v15051067.
10
Effectiveness and Safety of Palivizumab for the Prevention of Serious Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus: A Systematic Review.帕利珠单抗预防呼吸道合胞病毒引起的严重下呼吸道感染的有效性和安全性：系统评价。
Am J Perinatol. 2024 May;41(S 01):e1107-e1115. doi: 10.1055/a-1990-2633. Epub 2022 Nov 30.
呼吸道合胞病毒融合糖蛋白三聚体与一种预融合特异性中和抗体结合的结构。
Science. 2013 May 31;340(6136):1113-7. doi: 10.1126/science.1234914. Epub 2013 Apr 25.
4
Group- and genotype-specific neutralizing antibody responses against respiratory syncytial virus in infants and young children with severe pneumonia.婴幼儿重症肺炎患者中针对呼吸道合胞病毒的群体和基因型特异性中和抗体反应。
J Infect Dis. 2013 Feb 1;207(3):489-92. doi: 10.1093/infdis/jis700. Epub 2012 Nov 21.
5
A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis.一种稳定的呼吸道合胞病毒反向遗传学系统，适用于重组介导的诱变。
Virology. 2012 Dec 5;434(1):129-36. doi: 10.1016/j.virol.2012.09.022. Epub 2012 Oct 11.
6
The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and disease.呼吸道合胞病毒在出生队列中的自然史：年龄和既往感染对再感染和疾病的影响。
Am J Epidemiol. 2012 Nov 1;176(9):794-802. doi: 10.1093/aje/kws257. Epub 2012 Oct 11.
7
Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c mice.疫苗诱导的 CD8+ T 细胞可预防 BALB/c 小鼠呼吸道合胞病毒 A2 株 19F 诱导的发病机制。
J Virol. 2012 Dec;86(23):13016-24. doi: 10.1128/JVI.01770-12. Epub 2012 Sep 26.
8
The secreted G protein of human respiratory syncytial virus antagonizes antibody-mediated restriction of replication involving macrophages and complement.人呼吸道合胞病毒分泌的 G 蛋白拮抗涉及巨噬细胞和补体的抗体介导的复制限制。
J Virol. 2012 Oct;86(19):10880-4. doi: 10.1128/JVI.01162-12. Epub 2012 Jul 25.
9
Cost utility of palivizumab prophylaxis among pre-term infants in the United States: a national policy perspective.帕利珠单抗预防早产儿在美国的成本效用：国家政策视角。
J Med Econ. 2012;15(5):987-96. doi: 10.3111/13696998.2012.690013. Epub 2012 May 10.
10
Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.美国 1993-2008 年与流感和呼吸道合胞病毒相关的住院治疗情况。
Clin Infect Dis. 2012 May;54(10):1427-36. doi: 10.1093/cid/cis211. Epub 2012 Apr 10.